GLP-1 Family advanced
GLP-1 Agonist Renal Effects
Nephroprotective effects of GLP-1 receptor agonists including reduced albuminuria and improved renal outcomes.
By Encyclopeptide Editorial | 1 min read
GLP-1 renal nephropathy kidney albuminuria
Clinical Evidence
FLOW Trial (Semaglutide)
- Primary composite: 24% risk reduction (HR 0.76)
- Reduced progression to kidney failure
LEADER (Liraglutide)
- New-onset nephropathy: 22% reduction
Mechanisms of Renal Protection
- Natriuresis: Direct tubular GLP-1R effects
- Blood pressure reduction: 2-5 mmHg systolic
- Anti-inflammatory effects
- Anti-fibrotic effects
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Renal Effects |
| Category | GLP-1 Family |
References
- Encyclopeptide Database. “GLP-1 Agonist Renal Effects” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Renal Effects with interactive quizzes on Wikipept.
Take a Quiz on Wikipept